<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">diaendo</journal-id><journal-title-group><journal-title xml:lang="ru">Сахарный диабет</journal-title><trans-title-group xml:lang="en"><trans-title>Diabetes mellitus</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0351</issn><issn pub-type="epub">2072-0378</issn><publisher><publisher-name>Endocrinology research centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/2072-0351-816</article-id><article-id custom-type="elpub" pub-id-type="custom">diaendo-816</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Вопросы патогенеза</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Pathogenesis</subject></subj-group></article-categories><title-group><article-title>Роль метформина как донора оксида азота в регуляции углеводного обмена у пациентов с сахарным диабетом 2 типа</article-title><trans-title-group xml:lang="en"><trans-title>Metformin regulates glycemic homeostasis in patients with type 2 diabetes mellitus as an NO donor</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кузнецов</surname><given-names>Иван Сергеевич</given-names></name><name name-style="western" xml:lang="en"><surname>Kuznetsov</surname><given-names>Ivan Sergeevich</given-names></name></name-alternatives><email xlink:type="simple">ISKuznetsov@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сереженков</surname><given-names>Владимир Анатольевич</given-names></name><name name-style="western" xml:lang="en"><surname>Serezhenkov</surname><given-names>Vladimir Anatol'evich</given-names></name></name-alternatives><email xlink:type="simple">ISKuznetsov@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Романцова</surname><given-names>Татьяна Ивановна</given-names></name><name name-style="western" xml:lang="en"><surname>Romantsova</surname><given-names>Tatiana Ivanovna</given-names></name></name-alternatives><email xlink:type="simple">ISKuznetsov@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ванин</surname><given-names>Анатолий Федорович</given-names></name><name name-style="western" xml:lang="en"><surname>Vanin</surname><given-names>Anatoliy Fedorovich</given-names></name></name-alternatives><email xlink:type="simple">ISKuznetsov@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБОУ ВПО Первый Московский государственный медицинский университет им. И.М. Сеченова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>First Moscow State Medical University, Moscow</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Институт химической физики им. Н.Н.Семенова РАН</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Institute of Chemical Physics of Russian Academy of Sciences, Moscow</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>05</day><month>11</month><year>2013</year></pub-date><volume>16</volume><issue>3</issue><issue-title>Сахарный диабет</issue-title><fpage>41</fpage><lpage>45</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кузнецов И.С., Сереженков В.А., Романцова Т.И., Ванин А.Ф., 2013</copyright-statement><copyright-year>2013</copyright-year><copyright-holder xml:lang="ru">Кузнецов И.С., Сереженков В.А., Романцова Т.И., Ванин А.Ф.</copyright-holder><copyright-holder xml:lang="en">Kuznetsov I.S., Serezhenkov V.A., Romantsova T.I., Vanin A.F.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.dia-endojournals.ru/jour/article/view/816">https://www.dia-endojournals.ru/jour/article/view/816</self-uri><abstract/><trans-abstract xml:lang="en"/><kwd-group xml:lang="ru"><kwd>сахарный диабет 2 типа</kwd><kwd>оксид азота</kwd><kwd>динитрозильные комплексы железа</kwd></kwd-group><kwd-group xml:lang="en"><kwd>type 2 diabetes mellitus</kwd><kwd>nitrous oxide</kwd><kwd>dinitrosyl iron complex</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Higaki Y, Hirshman MF, Fujii N, Goodyear LJ. Nitric Oxide Increases Glucose Uptake Through a Mechanism That Is Distinct From the Insulin and Contraction Pathways in Rat Skeletal Muscle. Diabetes. 2001;50(2):241-247. DOI: http://dx.doi.org/10.2337/diabetes.50.2.241</mixed-citation><mixed-citation xml:lang="en">Higaki Y, Hirshman MF, Fujii N, Goodyear LJ. Nitric Oxide Increases Glucose Uptake Through a Mechanism That Is Distinct From the Insulin and Contraction Pathways in Rat Skeletal Muscle. Diabetes. 2001;50(2):241-247. DOI: http://dx.doi.org/10.2337/diabetes.50.2.241</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Nacci C, Tarquinio M, Montagnani M. Molecular and clinical aspects of endothelial dysfunction in diabetes. Internal and Emergency Medicine. 2009;4(2):107-116. DOI: http://dx.doi.org/10.1007/s11739-009-0234-7</mixed-citation><mixed-citation xml:lang="en">Nacci C, Tarquinio M, Montagnani M. Molecular and clinical aspects of endothelial dysfunction in diabetes. Internal and Emergency Medicine. 2009;4(2):107-116. DOI: http://dx.doi.org/10.1007/s11739-009-0234-7</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Lewandowska H, Brzóska K, Meczyńska-Wielgosz S, Rumianek K, Wójciuk G, Kruszewski M. Dinitrosyl iron complexes--structure and biological functions. Postepy Biochemii. 2010;56(3):298-304.</mixed-citation><mixed-citation xml:lang="en">Lewandowska H, Brzóska K, Meczyńska-Wielgosz S, Rumianek K, Wójciuk G, Kruszewski M. Dinitrosyl iron complexes--structure and biological functions. Postepy Biochemii. 2010;56(3):298-304.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Chazov EI, Rodnenkov OV, Zorin AV, Lakomkin VL, Gramovich VV, Vyborov ON, et al. Hypotensive effect of Oxacom(R) containing a dinitrosyl iron complex with glutathione: animal studies and clinical trials on healthy volunteers. Nitric Oxide. 2012;26(3):148-156. DOI: http://dx.doi.org/10.1016/j.niox.2012.01.008</mixed-citation><mixed-citation xml:lang="en">Chazov EI, Rodnenkov OV, Zorin AV, Lakomkin VL, Gramovich VV, Vyborov ON, et al. Hypotensive effect of Oxacom(R) containing a dinitrosyl iron complex with glutathione: animal studies and clinical trials on healthy volunteers. Nitric Oxide. 2012;26(3):148-156. DOI: http://dx.doi.org/10.1016/j.niox.2012.01.008</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Сереженков ВА, Ванин АФ, Шехтер АБ, Руденко ТГ, ГаврильчакАВ, Пекшев АВ. Динамика уровня эндогенного и экзогенного оксида азота в тканях раны и органах крыс (ЭПР-спектроскопическая оценка). В мат. науч-практ. конф. Под ред. Грачева С.В., Шехтер А.Б., Козлова Н.П. Москва; 2001. Стр. 35-40. [Serezhenkov VA, Vanin AF, Shekhter AB, Rudenko TG, Gavril'chakAV, Pekshev AV. Dinamika urovnya endogennogo i ekzogennogo oksida azota v tkanyakh rany i organakh krys (EPR-spektroskopicheskaya otsenka). Conference proceedings. Ed by Grachev S.V., Shekhter A.B., Kozlov N.P. Moscow; 2001. P. 35-40.]</mixed-citation><mixed-citation xml:lang="en">Сереженков ВА, Ванин АФ, Шехтер АБ, Руденко ТГ, ГаврильчакАВ, Пекшев АВ. Динамика уровня эндогенного и экзогенного оксида азота в тканях раны и органах крыс (ЭПР-спектроскопическая оценка). В мат. науч-практ. конф. Под ред. Грачева С.В., Шехтер А.Б., Козлова Н.П. Москва; 2001. Стр. 35-40. [Serezhenkov VA, Vanin AF, Shekhter AB, Rudenko TG, Gavril'chakAV, Pekshev AV. Dinamika urovnya endogennogo i ekzogennogo oksida azota v tkanyakh rany i organakh krys (EPR-spektroskopicheskaya otsenka). Conference proceedings. Ed by Grachev S.V., Shekhter A.B., Kozlov N.P. Moscow; 2001. P. 35-40.]</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Велиев ЕИ, Котов СВ, Шишло ВК, Сереженков ВА, Лозинский ВИ, Ванин АФ. Влияние динитрозильных комплексов железа с тиолсодержащими лигандами на состояние кавернозных тел пениса у крыс. Биофизика. 2008;53(2):326-335. [Veliev EI, Kotov SV, Shishlo VK, Serezhenkov VA, Vanin AF, Lozinsky VI. Beneficial effect of dinitrosyl iron complexes with thiol ligands on the rat penile cavernous bodies. Biophysics. 2008;53(2):153-157.]</mixed-citation><mixed-citation xml:lang="en">Велиев ЕИ, Котов СВ, Шишло ВК, Сереженков ВА, Лозинский ВИ, Ванин АФ. Влияние динитрозильных комплексов железа с тиолсодержащими лигандами на состояние кавернозных тел пениса у крыс. Биофизика. 2008;53(2):326-335. [Veliev EI, Kotov SV, Shishlo VK, Serezhenkov VA, Vanin AF, Lozinsky VI. Beneficial effect of dinitrosyl iron complexes with thiol ligands on the rat penile cavernous bodies. Biophysics. 2008;53(2):153-157.]</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">D'Autréaux B, Horner O, Oddou J-L, Jeandey C, Gambarelli S, Berthomieu C, et al. Spectroscopic Description of the Two Nitrosyl−Iron Complexes Responsible for Fur Inhibition by Nitric Oxide. Journal of the American Chemical Society. 2004;126(19):6005-6016. DOI: http://dx.doi.org/10.1021/ja031671a</mixed-citation><mixed-citation xml:lang="en">D'Autréaux B, Horner O, Oddou J-L, Jeandey C, Gambarelli S, Berthomieu C, et al. Spectroscopic Description of the Two Nitrosyl−Iron Complexes Responsible for Fur Inhibition by Nitric Oxide. Journal of the American Chemical Society. 2004;126(19):6005-6016. DOI: http://dx.doi.org/10.1021/ja031671a</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Henstridge DC, Drew BG, Formosa MF, Natoli AK, Cameron-Smith D, Duffy SJ, et al. The effect of the nitric oxide donor sodium nitroprusside on glucose uptake in human primary skeletal muscle cells. Nitric Oxide. 2009;21(2):126-131. DOI http://dx.doi.org/10.1016/j.niox.2009.06.002</mixed-citation><mixed-citation xml:lang="en">Henstridge DC, Drew BG, Formosa MF, Natoli AK, Cameron-Smith D, Duffy SJ, et al. The effect of the nitric oxide donor sodium nitroprusside on glucose uptake in human primary skeletal muscle cells. Nitric Oxide. 2009;21(2):126-131. DOI http://dx.doi.org/10.1016/j.niox.2009.06.002</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Paolisso G, Tagliamonte MR, Marfella R, Verrazzo G, D'Onofrio F, Giugliano D. L - arginine but not D-arginine stimulates insulin-mediated glucoseuptake. Metabolism. 1997;46(9):1068-1073. DOI: http://dx.doi.org/10.1016/j.niox.2009.06.002</mixed-citation><mixed-citation xml:lang="en">Paolisso G, Tagliamonte MR, Marfella R, Verrazzo G, D'Onofrio F, Giugliano D. L - arginine but not D-arginine stimulates insulin-mediated glucoseuptake. Metabolism. 1997;46(9):1068-1073. DOI: http://dx.doi.org/10.1016/j.niox.2009.06.002</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов ИИ, Шестакова МВ, Аметов АС, Анциферов МБ, Галстян ГР, Майоров ПЮ, Мкртумян АМ, Петунина НА, Сухарева ОЮ. Консенсус совета экспертов Российской Ассоциации Эндокринологов по инициации и интенсификации сахароснижающей терапии больных сахарным диабетом 2типа. Сахарный диабет. 2011;(4):6-17. [Dedov I.I., Shestakova M.V., Ametov A.S., Antsiferov M.B., Galstyan G.R., Mayorov A.Yu., Mkrtumyan A.M., Petunina N.F., Sukhareva O.Yu. Russian Association of Endocrinologists expert consensus document on initiation and intensification of antyhyperglycaemic therapy in type 2 diabetes mellitus. Diabetes mellitus. 2011;(4):6-17.] [Epub]</mixed-citation><mixed-citation xml:lang="en">Дедов ИИ, Шестакова МВ, Аметов АС, Анциферов МБ, Галстян ГР, Майоров ПЮ, Мкртумян АМ, Петунина НА, Сухарева ОЮ. Консенсус совета экспертов Российской Ассоциации Эндокринологов по инициации и интенсификации сахароснижающей терапии больных сахарным диабетом 2типа. Сахарный диабет. 2011;(4):6-17. [Dedov I.I., Shestakova M.V., Ametov A.S., Antsiferov M.B., Galstyan G.R., Mayorov A.Yu., Mkrtumyan A.M., Petunina N.F., Sukhareva O.Yu. Russian Association of Endocrinologists expert consensus document on initiation and intensification of antyhyperglycaemic therapy in type 2 diabetes mellitus. Diabetes mellitus. 2011;(4):6-17.] [Epub]</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Сереженков ВА, Кузнецов ИС, Романцова ТИ, Кузнецова МИ, Ванин АФ. Антидиабетический препарат «метформин» - донор оксида азота: ЭПР-спектроскопическая оценка эффективности действия «метформина». Биофизика. 2011;56(6):1125-1133. [Serezhenkov VA, Kuznetsov IS, Romantsova TI, Kuznetsova MI, Vanin AF. Antidiabetes drug metformin is a donor of nitric oxide: ESR measurement of efficiency. Biophysics. 2011;56(6):1125-1133.]</mixed-citation><mixed-citation xml:lang="en">Сереженков ВА, Кузнецов ИС, Романцова ТИ, Кузнецова МИ, Ванин АФ. Антидиабетический препарат «метформин» - донор оксида азота: ЭПР-спектроскопическая оценка эффективности действия «метформина». Биофизика. 2011;56(6):1125-1133. [Serezhenkov VA, Kuznetsov IS, Romantsova TI, Kuznetsova MI, Vanin AF. Antidiabetes drug metformin is a donor of nitric oxide: ESR measurement of efficiency. Biophysics. 2011;56(6):1125-1133.]</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Кузнецов ИС, Сереженков ВА, Ванин АФ, Романцова ТИ. Влияние метформина на биодоступность оксида азота у пациентов с сахарным диабетом 2 типа. Ожирение и метаболизм. 2012;(1):29-33. [Kuznetsov IS, Serezhenkov VA, Vanin AF, Romantsova TI. Effect of metformin on the bioavailability of nitric oxide in patients with type 2 diabetes. Obesity and metabolism. 2012;(1):29-33.]</mixed-citation><mixed-citation xml:lang="en">Кузнецов ИС, Сереженков ВА, Ванин АФ, Романцова ТИ. Влияние метформина на биодоступность оксида азота у пациентов с сахарным диабетом 2 типа. Ожирение и метаболизм. 2012;(1):29-33. [Kuznetsov IS, Serezhenkov VA, Vanin AF, Romantsova TI. Effect of metformin on the bioavailability of nitric oxide in patients with type 2 diabetes. Obesity and metabolism. 2012;(1):29-33.]</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
